About Cleerly
Cleerly is a Healthcare company based in Denver (United States) founded in 2016 by James Min. Atherosclerotic plaque is quantified by AI using coronary CT angiograms. Cleerly has raised $578.48 million across 5 funding rounds from investors including Fidelity Investments, Novartis and T. Rowe Price. Its chief executive, as recorded, is James Min. Its website cleerlyhealth.com draws about 46 thousand monthly visits. Cleerly offers products and services including Cleerly Software, Cleerly Plaque Analysis, and Cleerly ISCHEMIA. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is CLEERLY, INC. Its competitors include HeartFlow, Subtle Medical and Invicro; 3 of its 3 listed competitors have raised funding.
Company details
Cleerly was founded in 2016 in Denver, United States, as an AI-based platform for cardiac health assessment. Coronary CT angiograms are analyzed to characterize and quantify atherosclerotic plaque in arteries. Diagnostic capabilities are provided to healthcare providers, enabling identification of risks and support for employee health outcomes. Personalized care options are facilitated within the healthcare sector.
- Total Equity Funding$578.48M (USD)
in 5 rounds
- Latest Funding Round$106M (USD), Series C
Nov 2024
- InvestorsFidelity Investments
& 18 more
Products & Services of Cleerly
Cleerly offers a comprehensive portfolio of products and services, including Cleerly Software, Cleerly Plaque Analysis, and Cleerly ISCHEMIA.
AI tool for analyzing CCTA scans to detect heart disease risks.
Software for assessing arterial plaque to inform treatment strategies.
AI system for identifying ischemia in cardiac imaging.
Apps and channels of Cleerly
its YouTube channel Cleerly has 214 subscribers and 7 videos.
Videos from Cleerly
The most watched videos on Cleerly's YouTube channel, Cleerly (214 subscribers). Click a video to play it here.
More on Cleerly.
Funding Insights of Cleerly
Cleerly has successfully raised a total of $578.48M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $106 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $578.48M
- Total Rounds 5
- Last Round Series C — $106M
- First Round $14.48M
(Apr 2020)
- Investors Count 19
All 5 funding rounds of Cleerly with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $106M | Series C | – | Insight Partners | |
| Aug 2022 | $223M | Series C | – | T. Rowe Price, Fidelity Investments | |
| Mar 2022 | $192M | Series C | – | T. Rowe Price, Fidelity Investments | |
| Jun 2021 | $43M | Series B | – | Vensana Capital | |
| Apr 2020 | $14.48M | Series B | – | – | – |
19 investors in total: 17 institutional and 2 angel.
Investors in Cleerly
Cleerly has secured backing from 19 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Fidelity Investments, Novartis and T. Rowe Price.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment firm scaling software and technology companies from early to late stages. | insightpartners.com | |||
Investments in technology companies are conducted globally by Battery Ventures. | battery.com | |||
Investment management services are provided focusing on healthcare innovation. | puravidainvestments.com | New York, United States | ||
Investments in medical technology are made by Vensana Capital. | vensanacap.com | Minneapolis, United States | ||
Early stage venture capital firm investing in the US | lrvhealth.com | Boston, United States | ||
Stage-agnostic investments in US life sciences are managed. | 2005 | nlvpartners.com | New York, United States | |
VC firm focused on the healthcare industry | cignaventures.com | Bloomfield, United States | ||
Early-stage digital health companies are supported through venture capital investments. | 2016 | digitxpartners.com | San Francisco, United States | |
Growth stage tech & life sciences focused VC Firm investing in Asia and the US | sandscapitalventures.com | Arlington, United States | ||
Venture capital firm | breyercapital.com | Menlo Park, United States |
Investor details for Cleerly
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cleerly
55 people are tracked at Cleerly (31 in leadership, 24 in team).
| Name | Role | Group |
|---|---|---|
James Min | Founder & CEO | Leadership |
Edan Agashi | Regional Director Of Sales - West | Leadership |
Shane Reid | VP Of Engineering | Leadership |
Brian Flynn | Director, Market Access | Leadership |
Lance Thrash | VP Market Access and Reimbursement | Leadership |
Michael Rhodes | Vice President of Sales | Leadership |
Nick Tascione | Area Sales Director | Leadership |
Hélio Lourenço | Vp, Core Lab | Leadership |
Chelsea Bryant, MHA, CCHW | Program Director | Leadership |
Rebecca Cohenour | General Counsel & Chief Compliance Officer | Leadership |
Kara Walsh | Vice President of Strategic Programs | Leadership |
James P Earls MD, FSCCT | Chief Medical Officer | Leadership |
Jim Hartman | Chief Commercial Officer (cco) | Leadership |
June T. | Executive Assistant To Chief Executive Officer | Leadership |
Udo Hoffmann MD MPH | Chief Medical, Scientific, And AI Officer | Leadership |
Tami Crabtree | Senior Director Of Biometrics | Leadership |
Chung (Jan) Chan | Director Of Machine Learning | Leadership |
Marco Diaz, MBA | Vice President of Sales, Health Systems | Leadership |
Jordan Swift | Senior Operations Director | Leadership |
Vidhya Kumar | Senior Director Scientific Development and Strategy | Leadership |
35 more people are available in the full profile.
Complete people profiles for Cleerly
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cleerly
3 dated milestones of Cleerly across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Cleerly is founded.
- Funding First funding round of $14.5M.
- Funding Latest funding round, Series C, of $106.0M.
Competitors of Cleerly
Cleerly has 3 listed competitors in our database, 3 of them funded. They include HeartFlow, Subtle Medical and Invicro.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| heartflow.com | 2007 | Redwood, United States | $936.05M | 428 | Cardiovascular diagnostics are provided using CT scans and analytics. | |
| subtlemedical.com | 2017 | Palo Alto, United States | $18.3M | 23 | AI-driven solutions for medical diagnostic imaging are developed. | |
| invicro.com | 2008 | Boston, United States | $45.84M | 308 | Provide contract research imaging services and software |
Detailed competitors of Cleerly
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cleerly
The website of Cleerly (cleerlyhealth.com) receives about 45.7K visits a month.
- Monthly visits45.7K
▲ 21.2% vs previous month
Websites whose visitors overlap most with Cleerly. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| heartflow.com | 100% | 47.7K | #681,653 | View details | |
| avantehs.com | 95% | 38.2K | #838,638 | View details | |
| helloheart.com | 91% | 115.5K | #314,678 | View details | |
| alivecor.com | 88% | 134.8K | #257,821 | View details | |
| circlecvi.com | 88% | 19.1K | #1,405,266 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Cleerly
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Cleerly (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cleerly
Complete news archive for Cleerly
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cleerly
Cleerly was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Cleerly is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
James Min is the CEO of Cleerly, as recorded in our data. They have also founded this company.
Cleerly is a funded company, having raised a total of $578.48M across 5 funding rounds to date. The company's 1st funding round was a Series B of $14.48M, raised on Apr 2020.
Cleerly was founded in 2016 in Denver, United States, as an AI-based platform for cardiac health assessment. Coronary CT angiograms are analyzed to characterize and quantify atherosclerotic plaque in arteries. Diagnostic capabilities are provided to healthcare providers, enabling identification of risks and support for employee health outcomes. Personalized care options are facilitated within the healthcare sector.
Cleerly's top competitors include Subtle Medical, HeartFlow and Invicro.
Cleerly offers Cleerly Software, Cleerly Plaque Analysis, and Cleerly ISCHEMIA.
Cleerly has 19 investors. Key investors include Fidelity Investments, Novartis, T. Rowe Price, New Leaf Venture Partners, and Piper Sandler.
Cleerly operates through Cleerly, Inc..